Royal London Asset Management
NBIX icon

Royal London Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Royal London Asset Management’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$6.76M Sell
2025
Q1 		$6.3M Buy
2024
Q4 		$7.03M Hold
2024
Q3 		$5.94M Buy
2024
Q2 		$6.26M Hold
2024
Q1 		$6.27M Buy
2023
Q4 		$4.25M Hold
2023
Q3 		$3.63M Buy
2023
Q2 		$2.82M Buy